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Project AquaVitae (H2020) Case Study 10 (CS10) is tackling issues with the reproduction of 
pirarucu Arapaima gigas and tambaqui Colossoma macropomum. Regarding the air-breather 
A. gigas, considered a potential species for aquaculture, CS10 is tackling the lack of regular 
spawning under captive conditions, by testing hormonal therapies to both stimulate natural 
reproduction of pairs in earthen ponds, and also to attempt collection of semen and eggs. 
Regarding the tambaqui, already the second most farmed fish from Brazil, work is been done 
to identify a protocol for the large-scale production of triploid fish. This protocol would 
increase sustainability of the value chain, potentially enhancing production rates. A last task 
aims to characterize the development of intermuscular bones (IBs) along the early 
development of tambaqui. This characterization intends to provide predictive models to 
identify the type, number, and length variation of IBs and support future breeding programs of 
the species. To these goals, trials are taking place at Embrapa Fisheries and Aquaculture 
(Palmas-TO, Brazil) and Occidental Amazon (Manaus-AM), in collaboration with CAUNESP 
(Jaboticabal-SP, Brazil) and NOFIMA (Tromsø, Norway). A first trial with A. gigas tested 
application of slow-release Evac GnRHa (40µg.kg-1) implants twice in five couples (other 
three used as control): on the 4th-May, and then after a 21-day-window, on the 25th May 2021. 
Effects have been evaluated on gonad development through collection of ovarian biopsies, 
and on behavioural indicators of reproduction and spawning. Also, blood plasma has been 
collected for future analysis of sex steroids concentrations. For the identification of an optimal 
pressure shock protocol to produce triploid C. macropomum, trials have been designed to 
investigate the optimal time (post-fertilization) for pressure shock (8000 psi) application 
(Trial 1). Then, the optimal duration for this shock application (Trial 2) and finally the 
optimal shock intensity (Trial 3). Success of triploidization is being evaluated for each 
treatment/trial after validation of flow cytometry method for the species. A final task on C. 
macropomum is characterizing the development of the intermuscular bones (IBs) along 
ontogeny through morphological analyses (diaphanization, X-Ray and ultrasound) muscle and 
tendons in three families from 75 to 121 days-post-fertilization (DPF), showing little 
morphological variability within families at this early stage. 
